From proteome-wide Mendelian randomization and multi-omics integration to functional validation: TGFB3 as a prioritized candidate in gastric adenocarcinoma - Top-Institutions - MDSpire

From proteome-wide Mendelian randomization and multi-omics integration to functional validation: TGFB3 as a prioritized candidate in gastric adenocarcinoma

  • By

  • Luming Zhao

  • Chenxi Mao

  • Yimeng Xu

  • Kangjie Zhou

  • Mingtong Liang

  • Yiqian Han

  • Jingzhou Zhang

  • Yidong Hong

  • Nan Hu

  • Fenglei Wu

  • July 6, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Gastrointestinal Cancer

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Gastrointestinal Cancer

  • #3

    National University Hospital of Singapore
    National University Hospital of Singapore

    Singapore, Singapore

    Key Differentiators

    • Oncology
    • Gastrointestinal Cancer

  • #4

    National Healthcare Group of Singapore
    National Healthcare Group of Singapore

    Singapore, Singapore

    Key Differentiators

    • Oncology
    • Gastrointestinal Cancer

  • #5

    Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
    Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

    São Paulo, Brazil

    Key Differentiators

    • Oncology

Original Source(s)

From proteome-wide Mendelian randomization and multi-omics integration to functional validation: TGFB3 as a prioritized candidate in gastric adenocarcinoma

  • by Luming Zhao, Chenxi Mao, Yimeng Xu, Kangjie Zhou, Mingtong Liang, Yiqian Han, Jingzhou Zhang, Yidong Hong, Nan Hu, Fenglei Wu

  • July 6, 2026

Related Content

CFTR functions as a tumor suppressor in adenoid cystic carcinoma and its silencing reveals an associated vulnerability involving the Hsp70 chaperone system

MR-guided microwave ablation of liver tumors: outcomes in local tumor control and determinants of treatment success

Prostate Cancer Screening—Where We’ve Been, Where We Are, and What Comes Next